Health and Pharmaceuticals

What to watch for this earnings season

0 Comments
Profit growth will slow as companies deal with the collapse in commodities and continued weak sentiment.

Lew looms large at API meeting

0 Comments
Big protest vote received as retail billionaire angles for board seat.

Alchemia to sell assets, pass cash to shareholders

0 Comments
Another biotech play bites the dust following drug trial failure, strategic review.

API flags improved underlying profit

by AAP
Australian Pharmaceutical expects to lift H1 underlying profit by more than 20%.

Pfizer earnings slip on drug patent loss

by AFP
0 Comments
Revenue, profits fall less than expected in fourth quarter.

P&G earnings sink on stronger US dollar

0 Comments
Consumer products giant warns of tough year ahead as currency movements hit home.

ResMed lifts Q2 revenue

Global manufacturer of sleep treatment products posts double-digit revenue growth in December quarter.

Ley 'open' to Medicare policy options

by AAP
0 Comments
Rebate indexation cut, $5 rebate freeze remain on the table.

High times for medicinal marijuana IPO

by AAP
Medicinal marijuana firm Phytotech makes stellar float, shares double in value.

Johnson & Johnson beats expectations

by AP
0 Comments
​Healthcare giant surpasses market forecasts despite 28% profit drop in Q4.

CSL plunges on weak flu vaccine

Shares dive after US health institute flags less effective vaccine, Swiss franc gains.

Ansell CEO relocates to Belgium

Magnus Nicolin to split time between two main hubs in Brussels and New Jersey.

Medibank price in good health

Questions raised as to whether Canberra sold health insurer too cheaply as investors enjoy windfall.

The government must do some heavy lifting on obesity

29 comments
Australia has a growing obesity rate, but so far the government has taken a back-seat approach. Further apathy will end up costing us all billions.

Top ten tech innovations of 2014

0 Comments
Don’t be mesmerised by cool apps and flashy new gizmos – the top technology inventions of the year are ones that will have a lasting effect.

Avon Products settles bribery charges

by AP
0 Comments
Avon will pay $US135 million to settle criminal and civil charges after executives in China pleaded guilty to bribing officials there.

Sigma expects to pay dividend

Sigma Pharmaceuticals says recent acquisitions will contribute to strong revenue gains.

Leighton gains $540m hospital revenue

Leighton, Healthscope conclude deal on Sydney northern beaches project

KGB Interview: Medibank's George Savvides

1 comment
Medibank Private chief executive George Savvides outlines the company's plans for primary healthcare and its opportunities to lift profits.

What Hockey can learn from Medibank

8 comments
The government needs a lesson in how technology can drive down costs. The Treasurer and his Health Minister would do well to look closely at what George Savvides is doing.

Pages